Promoter methylation of DAP-kinase: Association with advanced stage in non-small cell lung cancer

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Advanced Stage 100%
• Promoter Methylation 100%
• Death-associated Protein Kinase 1 (DAPK1) 100%
• Methylation 26%
• Promoter Region 20%
• Tobacco 13%
• Fisher's Exact Test 13%
• Asbestos 13%
• Histology 6%
• Tumor 6%
• Calmodulin 6%
• Carcinogen Exposure 6%
• Tobacco Carcinogens 6%
• Tumor Metastasis 6%
• Tumor Size 6%
• Methylation Status 6%
• Apoptosis 6%
• Interferon-α (IFN-α) 6%
• Asbestos Exposure 6%
• Surgical Resection 6%
• KRAS mutation 6%
• TP53 mutation 6%
• Odds Ratio 6%
• Massachusetts General Hospital 6%
• Overall Survival 6%
• Clinical Factors 6%
• Quantitative Methylation-specific PCR (Q-MSP) 6%
• Non-associated 6%
• Statistical Significance 6%
• Demographic Factors 6%
• Serine-threonine Kinase 6%
• C-terminus 6%
• Human Tumors 6%
• Small Sample Size 6%
• Pathological Stage 6%
• Late-onset 6%
• Lymph Node Involvement 6%
• Hypermethylation 6%
• CpG Island 6%
• Stage II-III 6%
• Kinase Function 6%
• Death Domain 6%
• Fresh Frozen Tissue 6%
• Test Node 6%

Biochemistry, Genetics and Molecular Biology

• Methylation 100%
• Promoter Region 100%
• Protein Kinases 100%
• Mediator 6%
• Overall Survival 6%
• C-Terminus 6%
• Sample Size 6%
• Tumor Volume 6%
• Death Domain 6%
• Phosphotransferase 6%
• Kinase 6%
• P53 6%
• CpG Island 6%
• Serine 6%
• Threonine 6%
• Calmodulin 6%
• Interferon 6%
• Programmed Cell Death 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Death Associated Protein Kinase 100%
• Carcinogen 6%
• Protein P53 6%
• Overall Survival 6%
• Protein Serine Threonine Kinase 6%
• Neoplasm 6%
• Interferon 6%
• Calmodulin 6%
• Diseases 6%